Assessing psoriasis severity: Psychometric validation of overall physician global assessment.

Authors :: Taliercio V
Langner AU
Secrest AM
Duffin KC
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Mar; Vol. 86 (3), pp. 637-638. Date of Electronic Publication: 2021 Jan 16.
Publication Year :: 2022
Abstract: Competing Interests: Conflicts of interest Dr Duffin has been a consultant or investigator for Amgen, Abbvie, Janssen, Celgene, Novartis, Lilly, Ortho Dermatologics, Stiefel, Bristol-Myers Squib, Pfizer, UCB, Sienna, and Boehringer-Ingelheim, and is a nonpromotional speaker for Novartis. Drs Taliercio and Secrest and Ms Langner have no conflicts of interest to disclose.

Subjects :: Humans
Psychometrics
Quality of Life
Severity of Illness Index
Physicians
Psoriasis diagnosis

Full Text Access

Tools